JP5102434B2 - 皮膚品質を改良するための経口投与可能な組成物 - Google Patents
皮膚品質を改良するための経口投与可能な組成物 Download PDFInfo
- Publication number
- JP5102434B2 JP5102434B2 JP2004536974A JP2004536974A JP5102434B2 JP 5102434 B2 JP5102434 B2 JP 5102434B2 JP 2004536974 A JP2004536974 A JP 2004536974A JP 2004536974 A JP2004536974 A JP 2004536974A JP 5102434 B2 JP5102434 B2 JP 5102434B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- composition
- food
- diet
- orally administrable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Pediatric Medicine (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
生き物の生涯には、老化の特徴である様々な徴候は皮膚に現れ、主要な臨床的徴候は細かい線と深い皺の出現であり、これは年齢と共に増加しまたは目立ってくる。更に、皮膚の色は一般に変化し、刺激を拡散し、場合によっては末梢血管拡張がある部分に存在するようになることがある。これらの老化の徴候は、例えば紫外線、汚染物質、フリーラジカルまたは化学物質のような外界からの影響に皮膚を暴露することによって促進される。
従って、第一の態様では、本発明は、ヒトまたは動物の皮膚品質を改良するための経口投与可能な組成物であって、活性成分として細胞のエネルギー代謝を刺激する分子、酸化防止剤、またはそれらの組合せ混合物の有効量を経口的に許容可能なキャリヤー中に含んでなる、組成物を提供することを目的とする。
第一の態様は、皮膚品質を改良するための経口投与可能な組成物であって、活性成分として細胞のエネルギー代謝を刺激する分子、酸化防止剤、またはそれらの組合せ混合物の有効量を経口的に許容可能なキャリヤー中に含んでなる組成物に関する。
研究デザイン:
食餌介入は、12月齢マウスで3ヶ月間であった。総ての動物群は、自由に給餌を受けた。動物の体重を1週間に1回測定した。
雄マウスC57/BL6は、9週齢のものをIFFA credo (フランス)から入手した。3週間の適応後、マウス(12週齢)を1尾ずつ収容して、栄養介入までコントロール食餌Aを与えた。12月齢で、マウスを無作為に10尾ずつ5群(A、B、C、DおよびE)に分けた。食餌介入は3ヶ月間であり、マウスに食物および水を自由に与え、12時間ずつの明暗サイクルを受けさせた。
18%タンパク質(大豆およびホエー)、11%脂肪(大豆油)、59%炭水化物(澱粉+スクロース)および10%セルロースから構成されるコントロール食餌(食餌A)に、イチョウ抽出物(食餌D)、またはビタミンC、ビタミンE、ブドウ種子抽出物およびシステインを含んでなる酸化防止剤のカクテル(食餌B)および/またはL-カルニチン(それぞれ、食餌CおよびE)を追加した。これらの食餌は、下記の通りである:
食餌A-コントロール: 18%タンパク質(大豆およびホエー)、11%脂肪、59%炭水化物、5%セルロース。
食餌B-酸化防止剤のカクテル: 食餌A + 0.19%ビタミンC、0.03% ビタミンE、0.075%ブドウ種子抽出物、0.4%システイン。
食餌C: 食餌A + 0.3% L-カルニチン +食餌Cの酸化防止剤のカクテル。
食餌D: 食餌A + 0.0375%イチョウ抽出物(Linnea)。
食餌E: 食餌A + 0.3% L-カルニチン。
3ヶ月間の食餌介入の後、動物を屠殺して、標準化した生験材料を採取した。背側皮膚(正中線、下背部)皮膜毛を除いて集め、秤量し、0.5x0.5mmの正方形に切り刻んだ。これらをその重量の10倍容積の0.1%酢酸、1M NaCl中で4℃で一定攪拌を行いながら24時間抽出した。試料を、不溶分(残っている皮膜毛、表皮)を遠心分離によって除き、上部の脂質層、溶解した真皮を含む水性層、および不溶分を含むペレットを生じた。水性層を取っておき、タンパク質を測定した。この上清25μlに200μlのBCA試薬(製造業者の指示に従ってBCA試薬AをBCA試薬Bと予備混合, Pierce, Rockford, IL,米国)を追加し、一定攪拌を行いながら30秒間インキュベーションした。顕色を562nmで測定した。タンパク質濃度を、BSA標準曲線から計算した。
12月齢で開始した3ヶ月間の食餌介入の後、4種類の実験用食餌をコントロール食餌と比較した。皮膚を酸性の高塩緩衝液で抽出し、GAG並びに総タンパク質を抽出物測定した。抽出物のGAG含量を、表1に示す。表1は、皮膚のグリコサミノグリカン含量が、コントロール食餌Aと比較して食餌B、C、DおよびEで刺激されることを示している。
これらのデーターから、12月齢マウスでの様々な食餌B、C、DおよびEによる3ヶ月間の食餌介入により、GAG含量の月齢に依存する減少を逆転することができる。食餌介入は、GAG含量を若い皮膚で見られるパターンまで増加させるのに効率的であった。GAGは多量の間質液を結合するための有力な分子であるので、それらは間質水和を増加させ且つ皮膚老化の徴候を元に戻すことができる。
トウモロコシ約58重量%、トウモロコシグルテン約5.5重量%、チキンミール約22重量%、2.5%乾燥チコリー、1%カルニチン、0.1%ビタミンC、ビタミンE(150IU/kg)、0.05%ブドウ種子プロアントシアニジン抽出物、および酸化防止剤としての1%システインであって、残りが塩、ビタミンおよびミネラルであるものから、飼料混合物を作製する。
飼料混合物を、実施例2と同様に2%カルニチンおよび酸化防止剤として0.05%イチョウ抽出物を用いて調製する。次に、飼料混合物を実施例2と同様に加工する。乾燥ドッグフードは、特にイヌの年齢に関連した皮膚の変化を改良しまたは回復することを目的としている。
粉末100gに対して、タンパク質加水分解生成物15%、脂肪25%、炭水化物(マルトデキストリン37%、澱粉6%、スクロース12%を含む) 55%、1日必要量に見合うだけの微量のビタミンおよびオリゴ成分(oligoelements)、2%ミネラル、および3%水分、および2%ピルベート、および酸化防止剤としての1%カルノシンまたはカルノシン前駆体を含む栄養組成物を調製する。
皮膚品質を改良するための、特に皮膚におけるグリコサミノグリカン産生と沈着を刺激する毎日経口投与可能な組成物は、イチョウ抽出物240mgとGlucidex IT 19(マルトデキストリン粉末) QSP 500mgを含む。
Claims (2)
- ヒトの皮膚品質の改良を目的とする経口投与可能な食料栄養補給物を調製するための、L−カルニチン、システイン、ビタミンC、ビタミンE及びブドウ種子抽出物の使用。
- ヒトの皮膚年齢に関係した変化を予防しまたは回復することを目的とする経口投与可能な食料栄養補給物を調製するための、L−カルニチン、システイン、ビタミンC、ビタミンE及びブドウ種子抽出物の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02078707.3 | 2002-09-09 | ||
EP02078707 | 2002-09-09 | ||
PCT/EP2003/009687 WO2004026287A1 (en) | 2002-09-09 | 2003-09-01 | Orally administrable composition for improving skin quality |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006502176A JP2006502176A (ja) | 2006-01-19 |
JP5102434B2 true JP5102434B2 (ja) | 2012-12-19 |
Family
ID=32010972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004536974A Expired - Fee Related JP5102434B2 (ja) | 2002-09-09 | 2003-09-01 | 皮膚品質を改良するための経口投与可能な組成物 |
Country Status (15)
Country | Link |
---|---|
US (1) | US20050249826A1 (ja) |
EP (1) | EP1581199B1 (ja) |
JP (1) | JP5102434B2 (ja) |
KR (1) | KR20050057286A (ja) |
CN (1) | CN1681484B (ja) |
AU (1) | AU2003294667A1 (ja) |
BR (1) | BRPI0314066A8 (ja) |
CA (1) | CA2498141C (ja) |
ES (1) | ES2535778T3 (ja) |
HK (1) | HK1083746A1 (ja) |
MX (1) | MXPA05002652A (ja) |
MY (1) | MY166631A (ja) |
PT (1) | PT1581199E (ja) |
TW (1) | TW200404562A (ja) |
WO (1) | WO2004026287A1 (ja) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8034372B2 (en) | 2003-03-05 | 2011-10-11 | Nestec, Ltd. | Dietary supplement for athletic pets |
CN1917779B (zh) * | 2004-01-28 | 2010-06-16 | 雀巢技术公司 | 用于改善皮肤状况和防止皮肤病的营养组合物 |
EP1637149A1 (de) * | 2004-06-09 | 2006-03-22 | Medifood GmbH | Nahrungsergänzungsmittel für den Mann |
EP1830665A1 (en) * | 2004-12-31 | 2007-09-12 | DSMIP Assets B.V. | Pet food |
WO2007027092A2 (en) * | 2005-09-02 | 2007-03-08 | Campina Nederland Holding B.V. | Oral composition for moisturising skin |
WO2007062415A1 (en) * | 2005-11-26 | 2007-05-31 | Grinrx | Corporeal delivery of carotenoids |
US20070231371A1 (en) * | 2006-02-01 | 2007-10-04 | Nestec, S. A. | Nutritional system and methods for increasing longevity |
AU2007245002B2 (en) * | 2006-03-29 | 2012-05-03 | Société des Produits Nestlé S.A. | Dietary supplements containing probiotics |
RU2434642C2 (ru) * | 2006-04-12 | 2011-11-27 | Унилевер Н.В. | Пероральная композиция с эффектом, направленным против старения кожи |
ES2391305T3 (es) * | 2006-04-12 | 2012-11-23 | Unilever N.V. | Composición oral que comprende un ácido graso poliinsaturado y ácido salicílico para obtener un efecto antiinflamatorio en la piel |
WO2008007244A2 (en) * | 2006-06-08 | 2008-01-17 | The Iams Company | Composition for improving eye health |
JP4922137B2 (ja) * | 2007-11-16 | 2012-04-25 | 株式会社マルハニチロ食品 | ヒアルロン酸産生促進物質 |
DK2579733T3 (da) * | 2010-06-14 | 2014-10-13 | Abbott Lab | Ultralydsstøttet ekstrusionsmetoder til fremstilling af ernæringsmæssige pulverprodukter |
JP2013535461A (ja) * | 2010-07-30 | 2013-09-12 | ネステク ソシエテ アノニム | 皮膚色素沈着を調節するための焙煎コーヒー豆の使用 |
MX350475B (es) * | 2010-07-30 | 2017-09-07 | Loreal * | Uso de granos de café verdes para regular trastornos de pigmentación de la piel. |
MX350476B (es) * | 2010-07-30 | 2017-09-07 | Loreal * | Uso de una mezcla de granos de cafe tostados y verdes para regular pigmentacion de la piel. |
RU2013108969A (ru) * | 2010-07-30 | 2014-09-10 | Нестек С.А. | Применение зеленого кофе и пробиотика для регулирования пигментации кожи |
CN102783568B (zh) * | 2012-08-29 | 2014-05-14 | 山东中医药大学 | 一种饲料添加剂 |
CN103385516A (zh) * | 2013-07-29 | 2013-11-13 | 安徽燕之坊食品有限公司 | 一种液体补充物 |
MX2021004937A (es) | 2018-11-02 | 2021-06-08 | Unilever Ip Holdings B V | Glicerolesteres del acido nicotinico bioenergetico, composiciones y metodos para utilizar el mismo. |
WO2020222506A1 (ko) * | 2019-05-02 | 2020-11-05 | 주식회사 넥스모스 | 압타머를 유효성분으로 포함하는 경구용 조성물 |
WO2021255061A1 (en) | 2020-06-17 | 2021-12-23 | Société des Produits Nestlé S.A. | Stabilization of lc-pufas by side stream product from green coffee decaffeination |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839159A (en) * | 1988-02-08 | 1989-06-13 | Topicarn, Inc. | Topical L-carnitine composition |
US5686436A (en) * | 1993-05-13 | 1997-11-11 | Hiv Diagnostics, Inc. | Multi-faceted method to repress reproduction of latent viruses in humans and animals |
US5656588A (en) * | 1994-07-19 | 1997-08-12 | Wake Forest University | Wound healing formula |
US6602526B2 (en) * | 1996-02-23 | 2003-08-05 | Medical Doctors Research Institute | Oral compositions containing lotus |
AU3582597A (en) * | 1996-06-28 | 1998-01-21 | Viva America Marketing, Inc. | Nutritional supplement composition and use |
DE19649891C2 (de) * | 1996-12-02 | 1998-12-10 | Mk Produktkontor Gmbh | Verwendung von antioxidativen Zusammensetzungen mit Süßmolkekonzentrat |
JP3860335B2 (ja) * | 1998-04-20 | 2006-12-20 | 株式会社ホーメット | プロアントシアニジン含有滋養液及びその製造方法 |
IT1299191B1 (it) * | 1998-06-23 | 2000-02-29 | Sigma Tau Healthscience Spa | Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa |
JP4082823B2 (ja) * | 1999-05-06 | 2008-04-30 | 日本メナード化粧品株式会社 | 光毒性抑制剤 |
JP2001098267A (ja) * | 1999-09-30 | 2001-04-10 | Kobayashi Pharmaceut Co Ltd | 抗酸化剤及び活性酸素消去剤 |
JP2003529347A (ja) * | 2000-01-25 | 2003-10-07 | ジュヴェノン インコーポレイテッド | 高齢ペット用の栄養補給食品 |
WO2002011745A1 (en) * | 2000-08-04 | 2002-02-14 | Angiolab, Inc. | Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase |
US20020115710A1 (en) * | 2000-10-31 | 2002-08-22 | Zicker Steven Curtis | Composition and method |
FR2818136B1 (fr) * | 2000-12-15 | 2004-10-15 | Oreal | Composition, notamment cosmetique, comprenant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un inhibiteur de no-synthase |
CN1197473C (zh) * | 2001-01-02 | 2005-04-20 | 陈勇 | 胶基可食的功能性口香糖及其制作方法 |
US20030008048A1 (en) * | 2001-06-08 | 2003-01-09 | David Winston | Methods and compositions for helping the body resist the effects of the aging process |
-
2003
- 2003-09-01 ES ES03785600.2T patent/ES2535778T3/es not_active Expired - Lifetime
- 2003-09-01 CN CN038213354A patent/CN1681484B/zh not_active Expired - Fee Related
- 2003-09-01 US US10/527,097 patent/US20050249826A1/en not_active Abandoned
- 2003-09-01 JP JP2004536974A patent/JP5102434B2/ja not_active Expired - Fee Related
- 2003-09-01 EP EP03785600.2A patent/EP1581199B1/en not_active Expired - Lifetime
- 2003-09-01 CA CA2498141A patent/CA2498141C/en not_active Expired - Fee Related
- 2003-09-01 KR KR1020057004051A patent/KR20050057286A/ko not_active Application Discontinuation
- 2003-09-01 PT PT37856002T patent/PT1581199E/pt unknown
- 2003-09-01 BR BRPI0314066A patent/BRPI0314066A8/pt not_active Application Discontinuation
- 2003-09-01 WO PCT/EP2003/009687 patent/WO2004026287A1/en active Application Filing
- 2003-09-01 MX MXPA05002652A patent/MXPA05002652A/es active IP Right Grant
- 2003-09-01 AU AU2003294667A patent/AU2003294667A1/en not_active Abandoned
- 2003-09-09 MY MYPI20033394A patent/MY166631A/en unknown
- 2003-09-09 TW TW092124912A patent/TW200404562A/zh unknown
-
2006
- 2006-03-27 HK HK06103796.4A patent/HK1083746A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2498141A1 (en) | 2004-04-01 |
CN1681484B (zh) | 2012-06-06 |
WO2004026287A1 (en) | 2004-04-01 |
MY166631A (en) | 2018-07-17 |
MXPA05002652A (es) | 2006-04-28 |
CA2498141C (en) | 2012-07-10 |
BRPI0314066A8 (pt) | 2017-12-12 |
KR20050057286A (ko) | 2005-06-16 |
AU2003294667A1 (en) | 2004-04-08 |
BR0314066A (pt) | 2005-07-05 |
CN1681484A (zh) | 2005-10-12 |
TW200404562A (en) | 2004-04-01 |
HK1083746A1 (en) | 2006-07-14 |
EP1581199B1 (en) | 2015-02-25 |
PT1581199E (pt) | 2015-04-27 |
EP1581199A1 (en) | 2005-10-05 |
ES2535778T3 (es) | 2015-05-14 |
JP2006502176A (ja) | 2006-01-19 |
US20050249826A1 (en) | 2005-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5102434B2 (ja) | 皮膚品質を改良するための経口投与可能な組成物 | |
US9393253B2 (en) | Food composition comprising glucosamine | |
RU2350124C2 (ru) | Питательная композиция для улучшения состояния кожи и предотвращения кожных заболеваний | |
US8759405B2 (en) | Stevia extract or steviol for hair care | |
JP5013673B2 (ja) | 毛髪および外被品質を改良するための経口投与可能な組成物 | |
JP2008099562A (ja) | 美肌用経口組成物 | |
WO2009082883A1 (fr) | Composition anti-obésité | |
JP2007236308A (ja) | 食品組成物 | |
JP2012067082A (ja) | 経口組成物 | |
US20230096487A1 (en) | Undenatured Type II Collagen in Food and Beverage Applications and Uses Thereof | |
CN107205919A (zh) | 牛磺酸或其衍生物、生物素和葡萄提取物的组合用于对抗细的毛发的用途 | |
BRPI0800573A2 (pt) | suplemento nutricional à base de queratina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060403 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20061110 |
|
RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7425 Effective date: 20070314 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090602 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090902 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090909 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091002 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20091002 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20091215 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100415 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100617 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20100629 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100810 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101110 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20101203 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120928 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151005 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |